Treatment of severe autoimmune disease by stem-cell transplantation
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 435 (7042) , 620-627
- https://doi.org/10.1038/nature03728
Abstract
Transplantation of haematopoietic stem cells — cells capable of self renewing and reconstituting all types of blood cell — can treat numerous lethal diseases, including leukaemias and lymphomas. It may now be applicable for the treatment of severe autoimmune diseases, such as therapy-resistant rheumatoid arthritis and multiple sclerosis. Studies in animal models show that the transfer of haematopoietic stem cells can reverse autoimmunity, and several mechanistic pathways may explain this phenomenon. The outcome of ongoing clinical trials, as well as of studies in patients and animal models, will help to determine the role that stem-cell transplantation can play in the treatment of autoimmune diseases.Keywords
This publication has 65 references indexed in Scilit:
- Animal models have little to teach us about Type 1 diabetes: 1. In support of this proposalDiabetologia, 2004
- Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Bone Marrow Transplantation for Autoimmune DiseasesActa Haematologica, 1998
- Effect of Disease Stage on Clinical Outcome After Syngeneic Bone Marrow Transplantation for Relapsing Experimental Autoimmune EncephalomyelitisBlood, 1998
- Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells.Proceedings of the National Academy of Sciences, 1990
- Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation.Proceedings of the National Academy of Sciences, 1989
- Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue.Proceedings of the National Academy of Sciences, 1987
- Rationale for bone marrow transplantation in the treatment of autoimmune diseases.Proceedings of the National Academy of Sciences, 1985
- Combined short‐term immunotherapy for experimental autoimmune myasthenia gravisAnnals of Neurology, 1983
- Transplantation of Autoimmune Potential. I. Development of Antinuclear Antibodies in H-2 Histocompatible Recipients of Bone Marrow from New Zealand Black MiceProceedings of the National Academy of Sciences, 1974